Upload
rory
View
29
Download
0
Embed Size (px)
DESCRIPTION
Acute respiratory distress syndrome. ALOK SINHA Department of Medicine Manipal College of Medical Sciences Pokhara , Nepal. alveolar epithelium. Serious disease characterised by damage to alveolar epithelium & capillary endothelium resulting in alveolar oedema with high protein fluid - PowerPoint PPT Presentation
Citation preview
ALOK SINHADepartment of Medicine
Manipal College of Medical SciencesPokhara, Nepal
• Serious disease characterised by damage to alveolar epithelium & capillary endothelium resulting in alveolar oedema with high protein fluid
• It results from increased alveolar capillary permeability
• NOT CARDIOGENIC IN ORIGIN
alveolar epitheliumCapillary endothelium
severe end of a spectrum of acute lunginjury due to many different insults.Essentially it is diffuse alveolar injury
Acute, persistent, lung inflammation
Increased vascular permeability
Bilateral and extensive infiltrates (seen in the CXR)
Very poor oxygenation despite PEEP
Not due to clinical left ventricular failure – associated with a wedge pressure of over 18 mmHg (non-cardiogenic)
Most commonly seen on the ICU where about 10% of such patients will have ARDS
PCWP Normal: 8-12mmHg
International criteria1. Acute onset of symptoms
2. PaO2 : FIO2 (fraction of inspired oxygen) – 200 mm Hg or lessFor Example normal PaO2 = 100, FiO2 = 20% or 1/5 so the above ratio = 100/1/5 = 500 mm Hg
3. Bilateral infiltrates on CXRs
4. Pulmonary arterial wedge pressure of 18 mm Hg or less (or no clinical signs of left atrial hypertension)
Increased alveolar-arterial (A-a) gradient
A
a
What is this situation ?
1. Acute onset of symptoms
2. PaO2 : FIO2: between 300 to 200 mm Hg
3. Bilateral infiltrates on CXRs
4. Pulmonary arterial wedge pressure of 18 mm Hg or less or no clinical signs of left atrial hypertension
•Acute lung injury (ALI)
ALI ARDSMild
Pathogenesis of ARDS
Inflammatory damage to the alveoli– by locally produced pro-inflammatory mediators– remotely produced and arriving via
pulmonary arteryThrough inhalation (eg gastric contents)
Increased pulmonary capillary permeability - fluid and protein leakage into the alveolar spaces with pulmonary infiltrates
Alveolar surfactant is diluted with loss of its stabilizing effect, resulting in diffuse alveolar collapse and stiff lungs. This leads to:
1. Gross impairment of V/Q matching with shunting causing arterial hypoxia – usually enough remaining functioning alveoli to
maintain CO2 clearance- Normal CO2– Pulmonary hypertension will develop secondary to
the hypoxia (helpful – counters V/Q matching)
2.Reduced compliance (stiff lungs), due to loss of functioning alveoli alveolar collapse, filled with fluid and protein hyperinflation of remaining alveoli to their limits of
distension
Decrease transfer of gases in alveoli3.
Causes of mediator release leading to ARDSSepsis/pneumonia
Gastric aspiration
Major trauma
Smoke/ gas inhalation
Acute pancreatitis
Drug toxicity - tricyclic antidepressants, opiates, cocaine, aspirin
Fat emboli
Direct effects of large amounts of necrotic tissue
(secondary risk factors) alcoholism
cigarette smoking
Less common causes
Near drowning
Following upper airway obstruction: mechanism unclear
Acute form of Interstitial Pneumonia: Also known as acute Hamman-Rich syndrome
Post-bone marrow transplant as bone marrow recovers
Amniotic embolism
Massive haemorrhage
Multiple transfusions
DIC
Massive burns
Head injury– Raised ICP– Intracranial bleed
Cardio-pulmonary bypass
Acute liver failure
Course of ARDS
Phase 1 - early period of alveolar damage and hypoxaemia with pulmonary infiltration
Phase 2 -develops after a week as pulmonary infiltrates resolve– associated with an increase in
type II pneumocytes (surfactant producers)
Myofibroblasts
collagen formation
Phase 3 -if the patient survives, is the fibrotic stage that leaves the lung with –Cysts–deranged micro-architecture – fibrosis on histology
leading to Cor Pulmonale
ARDS should be considered in any patient with a predisposing risk factor develops severe hypoxaemia stiff lungswidespread diffuse pulmonary infiltrate
Approximately 1 to 2 days following the clinical presentation of the precipitating cause
Rapidly worsening dyspnoea Dry cough HypoxaemiaCoarse crackles in the chest
DIFFERENTIALS
Aspiration Pneumonia
Congestive Heart Failure
Pneumonia Atypical Bacterial Pneumonia
Pneumocystis Carinii
Pneumonia Viral
To exclude other more specifically treatable conditions
Left ventricular failure excluded – on clinical grounds– by echocardiography– wedge pressure measurement <18 mmHg.
Diffuse alveolar haemorrhage can occur in Goodpasture's, Leptospirosis
Oher clinical features of these disorders will be present
Some pulmonary infections – Mycobacteria– Legionella– PCP– viral pneumonia
may mimic ARDS & lavage fluid may reveal these
Occasionally cancer and lymphangitis carcinomatosa can also mimic ARDS – will show on a lung biopsy
CXRABG (consider arterial line as regular samples may be required)CBC,LFTs, coagulation profile, and CRPSeptic screen (culture blood, urine, sputum)ECGConsider drug screenAmylase if history suggestive
Pulmonary artery catheter to measure – PCWP– cardiac output– mixed venous oxygen saturation – calculation of haemodynamic parameters
Other investigations if appropriate–CT chest–Broncho alveolar lavage for microbiology &
cell count (?eosinophils)
Treat the precipitating cause
Provide best supportive care with adequate oxygenation
I.V. fluids – – to be used judiciously– Can increase pulmonary oedema
Inotrope and/or vasopressor support is commonly required and the choice of agent is – dobutamine – dopamine– epinephrine, norepinepherine
Patients invariably require higher oxygen concentrations (non-rebreather masks with reservoir FiO2 ~60- 80%) or CPAP
Consider transfer to HDU/ICU
Different oxygen delivery systems
Nasal canulaNon re breather masks
Indications for mechanical ventilation– Inadequate oxygenation (PaO2 <60mm
(8kPa) on FiO2 >0.6 or 60%)–Rising or elevated PaCO2 (> 45 mm or 6kPa)–Clinical signs of incipient
respiratory/cardiovascular failure
Mechanical ventilation with PEEP -almost always required to maintain oxygenation, with high inflation pressures
Is this the meaning of PEEP ?
PEEP: required to counter atelectasis
High inflation pressures may worsen ARDS directly (micro-barotrauma)– try to maintain plateau pressures <30 mmHg
Special ventilation techniques have been tried to reduce the high inflation pressures resulting from the stiff lungs (low compliance)
Using low tidal volumes to reduce inflation pressures (6 ml/kg ideal body weight compared to 12 ml/kg) reduces mortality by 10%
This results in Reduced minute ventilation
Rise in PaCO2 – permissive hypercapnia
• Inverse ratio ventilation • may improve oxygenation, but pCO2 may
rise further
• Prone positioning• improves oxygenation in ~70% of patients
with ARDS
• Inhaled pulmonary vasodilators (nitric oxide, nebulized prostacyclin): • may improve oxygenation
Extracorporeal oxygenation/CO2 removal will buy time and allow the lung to recover, but these techniques are very expensive and it is difficult to demonstrate any long-term benefit
High-dose steroids ––some evidence of overall improved survival – later use possibly beneficial if nosocomial
infection rates are not increased
Cardiovascular supportMost patients haemodynamically compromised
due to – underlying condition – ventilatory management
Benefit from fluid resuscitation. This may risk worsening capillary leak in the lung and compromise oxygenation/ventilation. Aim for a low-normal intravascular volume whilst maintaining cardiac index and mean arterial pressure
Management of other associated conditions• Renal failure • Enteral feeding • Coagulopathy -severe/DIC may be present expert
advice should be sought• Sepsis
empiric antibiotics guided by possible pathogens, and following an appropriate sensitivity tests Antibiotics should be modified or discontinued in light of microbiological results
Complications
High ventilation pressures lead to barotrauma: –pneumothorax –surgical emphysema –pneumomediastinum – Nosocomial infections
Non-specific problems of – venous thromboembolism– GI haemorrhage– inadequate nutrition
Prognosis
has improved over the last 20 years due to improvements in supportive care of –Early deaths due to the precipitating condition – later deaths to complications
Over half the patients will survive with varying residual lung damage, pulmonary function tests often show only minor restrictive abnormalities
Future developments
The optimal level of PEEP is difficult to predict. – Inadequate PEEP allows more atelectasis – too high PEEP contributes to overdistension of
remaining alveoli and further barotrauma
Ways to estimate the best PEEP are under investigation
Liquid ventilation with perfluorocarbons has been tried
Nitric oxide (NO) has been tried with clear improvements in oxygenation but very little effect on survival
Inhaled prostacyclin: is unconvincing
bilateral patchy opacities in mostly the middle and lower lung zones
Normal size heart No pleural effusion
.
It appears he is ticking ‘n’ alive